Thorne R G, Pronk G J, Padmanabhan V, Frey W H
Department of Pharmaceutics, University of Minnesota, Minneapolis, MN 55455, USA.
Neuroscience. 2004;127(2):481-96. doi: 10.1016/j.neuroscience.2004.05.029.
We investigated the CNS delivery of insulin-like growth factor-I (IGF-I), a 7.65 kDa protein neurotrophic factor, following intranasal administration and the possible pathways and mechanisms underlying transport from the nasal passages to the CNS. Anesthetized adult male Sprague-Dawley rats were given [125I]-IGF-I intranasally or intravenously and then killed by perfusion-fixation within 30 min. Other animals were killed following cisternal puncture and withdrawal of cerebrospinal fluid (CSF) or intranasal administration of unlabeled IGF-I or vehicle. Both gamma counting of microdissected tissue and high resolution phosphor imaging of tissue sections showed that the tissue concentrations and distribution following intranasal administration were consistent with two routes of rapid entry into the CNS: one associated with the peripheral olfactory system connecting the nasal passages with the olfactory bulbs and rostral brain regions (e.g. anterior olfactory nucleus and frontal cortex) and the other associated with the peripheral trigeminal system connecting the nasal passages with brainstem and spinal cord regions. Intranasal administration of [125I]-IGF-I also targeted the deep cervical lymph nodes, consistent with their possible role in lymphatic drainage of both the nasal passages and the CNS. Cisternal CSF did not contain [125I]-IGF-I following intranasal administration. Intravenous [125I]-IGF-I resulted in blood and peripheral tissue exposure similar to that seen following intranasal administration but CNS concentrations were significantly lower. Finally, delivery of IGF-I into the CNS activated IGF-I signaling pathways, confirming some portion of the IGF-I that reached CNS target sites was functionally intact. The results suggest intranasally delivered IGF-I can bypass the blood-brain barrier via olfactory- and trigeminal-associated extracellular pathways to rapidly elicit biological effects at multiple sites within the brain and spinal cord.
我们研究了鼻内给药后胰岛素样生长因子-I(IGF-I,一种7.65 kDa的蛋白质神经营养因子)向中枢神经系统(CNS)的递送情况,以及从鼻腔到中枢神经系统转运的可能途径和机制。对成年雄性Sprague-Dawley大鼠进行麻醉后,经鼻内或静脉内给予[125I]-IGF-I,然后在30分钟内通过灌注固定处死。其他动物在进行小脑延髓池穿刺并抽取脑脊液(CSF)后处死,或经鼻内给予未标记的IGF-I或赋形剂后处死。对显微解剖组织进行γ计数以及对组织切片进行高分辨率磷光成像均显示,鼻内给药后的组织浓度和分布与快速进入中枢神经系统的两条途径一致:一条与将鼻腔与嗅球及脑前部区域(如前嗅核和额叶皮质)相连的外周嗅觉系统相关,另一条与将鼻腔与脑干和脊髓区域相连的外周三叉神经系统相关。经鼻内给予[125I]-IGF-I还靶向颈深淋巴结,这与其在鼻腔和中枢神经系统淋巴引流中的可能作用一致。鼻内给药后,小脑延髓池脑脊液中未检测到[125I]-IGF-I。静脉内给予[125I]-IGF-I导致血液和外周组织暴露情况与鼻内给药相似,但中枢神经系统中的浓度显著较低。最后,将IGF-I递送至中枢神经系统激活了IGF-I信号通路,证实到达中枢神经系统靶位点的部分IGF-I功能完整。结果表明,经鼻内递送的IGF-I可通过与嗅觉和三叉神经相关的细胞外途径绕过血脑屏障,从而在脑和脊髓内的多个位点迅速引发生物学效应。